Endocrine

, Volume 27, Issue 2, pp 201–212

Melatonin, aging, and age-related diseases

Perspectives for prevention, intervention, and therapy
Article

Abstract

The high incidence of age-related diseases in the increasing population of elderly people has stimulated interest in the search for protective agents that have the capability of preventing premature aging and delaying the onset of degenerative disorders. To preserve health in old age becomes a primary goal for biomedicine, because the increasing longevity in our societies is associated with a rise in morbidity. The difficulties in finding new approaches and safe strategies for prevention, intervention, and treatment are related to the lack of theoretical background as well as to insufficient models to test the efficacy of anti-aging agents. Melatonin is a prime candidate for slowing the aging process and targeting its underlying pathology. Melatonin has profound gerontoprotective and antioxidant activities. Because enhanced oxidative stress plays a crucial role in the aging process and chronic diseases associated with senescence, the adminstration of a potent amphiphilic antioxidant agent with high bioavailability such as melatonin may become a promising, safe, and effective intervention strategy to slow aging and the initiation and progression of age-related disorders. Investigations on melatonin and its anti-aging activity may be of great benefit in increasing life quality of the elderly.

Key Words

Adaptogen aging antioxidant life span melatonin neuroprotection 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Reiter, R. J., Tan, D.-X., Mayo, J. C., Sainz, R. M., and Lopez-Burillo, S. (2002). Free Radic. Res. 36, 1323–1329.PubMedCrossRefGoogle Scholar
  2. 2.
    Reiter, R. J., Tan, D.-X., and Burkhardt, S. (2002). Mech. Ageing Dev. 30, 1007–1019.CrossRefGoogle Scholar
  3. 3.
    Kasarek, K. (2004). Exp. Gerontol. 39, 1723–1729.CrossRefGoogle Scholar
  4. 4.
    Poeggeler, B. (1993). Experientia 49, 611–613.PubMedCrossRefGoogle Scholar
  5. 5.
    Poeggeler, B., Reiter R. J., Tan, D.-X., Chen L.-D., and Manchester, L. C. (1993). J. Pineal Res. 14, 151–168.PubMedCrossRefGoogle Scholar
  6. 6.
    Reiter, R. J. (1992). Bioessays 14, 169–175.PubMedCrossRefGoogle Scholar
  7. 7.
    Wu, Y.-H. and Swaab, D. F. (2005). J. Pineal Res. 38, 145–152.PubMedCrossRefGoogle Scholar
  8. 8.
    Pandi-Perumal, S. R., Seils, L. K., Kayumow, L., et al. (2002). Aging Res. Rev. 1, 559–604.CrossRefGoogle Scholar
  9. 9.
    Armstrong, S. M. and Redman, J. R. (1991). Med. Hypothesis 34, 300–309.CrossRefGoogle Scholar
  10. 10.
    Acuña-Castroviejo, D., Escames, G., León, J., Carazo, A., and Khaldy, H. (2003). Adv. Exp. Med. Biol. 527, 549–557.PubMedGoogle Scholar
  11. 11.
    Haimov, I. and Lavie, P. (1997). Arch. Gerontol. Geriatr. 24, 167–173.PubMedCrossRefGoogle Scholar
  12. 12.
    Okatani, Y., Wakatusi, A., Reiter, R. J., and Miyahara, Y. (2003). Int. J. Biochem. Cell Biol. 35, 367–375.PubMedCrossRefGoogle Scholar
  13. 13.
    Reiter, R. J. (1980). Endocr. Res. 1, 109–131.CrossRefGoogle Scholar
  14. 14.
    Malm, O. J., Skaug, O. E., and Lingjaerde, P. (1959). Acta Endocrinol. 30, 22–28.PubMedGoogle Scholar
  15. 15.
    Reiter, R. J., Tan, D.-X., Kim, S. J., Manchester, L. C., Qu, W., and Garay, V. (1999). Mech. Ageing Dev. 110, 157–173.PubMedCrossRefGoogle Scholar
  16. 16.
    Anisimov, V. N. (2001). Exp. Gerontol. 36, 1101–1136.PubMedCrossRefGoogle Scholar
  17. 17.
    Reiter, R. J. (2004). J. Pineal Res. 37, 213–214.PubMedCrossRefGoogle Scholar
  18. 18.
    Anisimov, V. N., Zavarzina, N. Y., Zabezhinski, M. A., et al. (2001). J. Gerontol. 56A, B311-B323.Google Scholar
  19. 19.
    Turek, F. W. (1996). Nature 379, 295–296.PubMedCrossRefGoogle Scholar
  20. 20.
    Poeggeler, B. (2004). Ninth International Conference on Alzheimer’s Disease and Related Disorders, Philadelphia, PA, abstract P4–398.Google Scholar
  21. 21.
    Terron, M. P., Cubero, J., Marchena J. M., Barriga, C., and Rodriguez, A. B. (2002). Exp. Gerontol. 37, 421–426.PubMedCrossRefGoogle Scholar
  22. 22.
    Sharman, E. H., Sharman, K. G., Ge, Y.-W., Lahiri, D. K., and Bondy, S. C. (2004). J. Pineal Res. 36, 165–170.PubMedCrossRefGoogle Scholar
  23. 23.
    Magri, F., Sarra, S., Cinchetti, W., et al. (2004). J. Pineal Res. 36, 256–261.PubMedCrossRefGoogle Scholar
  24. 24.
    Lahiri, D. K., Ge, Y. W., Sharman, E. H. and Bondy, S. C. (2004). J. Pineal Res. 36, 217–223.PubMedCrossRefGoogle Scholar
  25. 25.
    Pierpaoli, W., Dall’Ara, A., Pedrinis, E., and Regelson, W. (1991). Ann. NY Acad. Sci. 621, 291–313.PubMedCrossRefGoogle Scholar
  26. 26.
    Pierpaoli, W. and Regelson, W. (1994). Proc. Natl. Acad. Sci. USA 91, 787–791.PubMedCrossRefGoogle Scholar
  27. 27.
    Grad, B. R. and Rozencweig, R. (1993). Psychoneuroendocrinology 18, 283–295.PubMedCrossRefGoogle Scholar
  28. 28.
    Kloeden, P. E., Rössler, R., and Rössler, O. E. (1993). Exp. Gerontol. 28, 109–118.PubMedCrossRefGoogle Scholar
  29. 29.
    Zhadanova, I. V., Wurtman, R. J., Regan, M. M., Taylor, J. A., Shi, J. P., and Leclair, O. U. (2001). J. Clin. Endocrinol. Metab. 86, 4727–4730.CrossRefGoogle Scholar
  30. 30.
    Hardeland, R., Coto-Montes, A., and Poeggeler, B. (2003). Chronobiol. Int. 20, 921–962.PubMedCrossRefGoogle Scholar
  31. 31.
    Hardeland, R. and Poeggeler, B. (2003). J. Pineal Res. 34, 233–241.PubMedCrossRefGoogle Scholar
  32. 32.
    Fletcher, R. A. and Sopher C. (1997). Fifth Canadian Pineal and Melatonin Symposium, Guelph, abstract 7.Google Scholar
  33. 33.
    Thomas, J. N. and Smith-Sonneborn, J. (1997). J. Pineal Res. 23, 123–130.PubMedCrossRefGoogle Scholar
  34. 34.
    Poeggeler, B. (1998). In: Reactive oxygen species in biological systems. Gilbert, D. L. and Colton, C. D. (eds.). Plenum Press: New York, pp. 421–451.Google Scholar
  35. 35.
    Izmaylov, D. M. and Obukhova, L. K. (1999). Mech. Ageing Dev. 106, 233–240.PubMedCrossRefGoogle Scholar
  36. 36.
    Bonilla, E., Medina-Leendertz, S., and Diaz, S. (2002). Exp. Gerontol. 37, 629–638.PubMedCrossRefGoogle Scholar
  37. 37.
    Baekev, V. V., Efremov, A. V., and Anisimov, V. N. (1997). Worm Breeder Gaz. 15, 36.Google Scholar
  38. 38.
    Lenz, S. P., Izui, S., Benediktsson, H., and Hart, D. A. (1995). Int. J. Immunopharmacol. 17, 581–592.PubMedCrossRefGoogle Scholar
  39. 39.
    Mocchegiani, E., Santarelli, L., Tibaldi, A., et al. (1998). J. Neuroimmunol. 86, 111–122.PubMedCrossRefGoogle Scholar
  40. 40.
    Lipman, R. D., Bronson, R. T., Wu, D., et al. (1998). Mech. Ageing Dev. 103, 269–284.PubMedCrossRefGoogle Scholar
  41. 41.
    Oxenkrug, G., Requintina, P., and Bachurin, S. (2001). Ann. NY Acad. Sci. 939, 190–199.PubMedCrossRefGoogle Scholar
  42. 42.
    Anisimov, V. N., Alimova, I. N., Baturin, D. A., et al. (2003). Exp. Gerontol. 38, 449–461.PubMedCrossRefGoogle Scholar
  43. 43.
    Semenchenko, G. V., Anisimov, V. N., and Yashin, A. I. (2004). Exp. Gerontol. 39, 1499–1511.PubMedCrossRefGoogle Scholar
  44. 44.
    Oaknin-Bendahan, S. Y., Anis, I., Nir, I., and Zisapel, N. (1995). Neuroreport 6, 785–788.PubMedCrossRefGoogle Scholar
  45. 45.
    Matsubara, E., Bryant-Thomas, T., Pacheco Quinto, J., et al. (2003). J. Neurochem. 85, 1101–1108.PubMedCrossRefGoogle Scholar
  46. 46.
    Manda, K. and Bhatia, A. L. (2003). Biogerontology 4, 133–139.PubMedCrossRefGoogle Scholar
  47. 47.
    Castillo, C., Salazar, V., Ariznavarreta, C., Vara, E., and Tresguerres, J. A. F. (2005). J. Pineal Res. 38, 240–246.PubMedCrossRefGoogle Scholar
  48. 48.
    Floyd, R. A., Hensley, K., Forster, M. J., Kelleher-Andersson J. A., and Wood, P. L. (2002). Mech. Ageing Dev. 30, 1021–1031.CrossRefGoogle Scholar
  49. 49.
    Harman, D. (1956). Gerontology 11, 298–300.Google Scholar
  50. 50.
    Harman, D. (1972). J. Am. Geriatr. Soc. 11, 298–300.Google Scholar
  51. 51.
    Gilbert, D. L. (2000). Ann. NY Acad. Sci. 899, 1–14.PubMedCrossRefGoogle Scholar
  52. 52.
    Enesco, H. E. and Verdone-Smith, C. (1980). Exp. Gerontol. 15, 335–338.PubMedCrossRefGoogle Scholar
  53. 53.
    Durand, D., Polidori, A., Salles J. P., and Pucci, B. (2003). Bioorg. Med. Chem. Lett. 13, 859–862.PubMedCrossRefGoogle Scholar
  54. 54.
    Menendez-Peleaz, A., Poeggeler, B., Reiter, R. J., Barlow-Walden, L. R., Pablos, M. I., and Tan, D.-X. (1993). J. Cell. Biochem. 53, 373–382.CrossRefGoogle Scholar
  55. 55.
    Menendez-Peleaz, A. and Reiter, R. J. (1993). J. Pineal Res. 15, 59–69.CrossRefGoogle Scholar
  56. 56.
    León, J., Acuña-Castroviejo, D., Escames, G., Tan, D.-X., and Reiter, R. J. (2005). J. Pineal Res. 38, 1–9.PubMedCrossRefGoogle Scholar
  57. 57.
    Fosslien, E. (2001). Ann. Clin. Lab. Sci. 31, 25–67.PubMedGoogle Scholar
  58. 58.
    Kelly, R. W., Amato, F., and Seamark, R. F. (1984). Biochem. Biophys. Res. Commun. 121, 371–379.CrossRefGoogle Scholar
  59. 59.
    Chyan, Y.-J., Poeggeler, B., Omar, R. A., et al. (1999). J. Biol. Chem. 274, 21937–21942.PubMedCrossRefGoogle Scholar
  60. 60.
    Marangos, P. J., Patel, J., Hirata, F., et al. (1981). Life Sci. 29, 259–267.PubMedCrossRefGoogle Scholar
  61. 61.
    Jorda, E. G., Jimerez, A., Verdaquer, E., et al. (2005). Apoptosis 10, 91–104.PubMedCrossRefGoogle Scholar
  62. 62.
    Ferrari, C. K. (2004). Biogerontology 5, 275–289.PubMedCrossRefGoogle Scholar
  63. 63.
    Seabra, M. L., Bignotto, M., Pinto, L. R. Jr., and Tufik, S. (2000). J. Pineal Res. 29, 193–200.PubMedCrossRefGoogle Scholar

Copyright information

© Humana Press Inc. 2005

Authors and Affiliations

  1. 1.Laboratories of Metabolism Research, Institute of Zoology, Anthropology and Developmental BiologyGeorg-August-University GoettingenGoettingenGermany

Personalised recommendations